Drug Profile
Enokizumab
Alternative Names: 7F3com-2H2; Anti-IL-9 monoclonal antibody - Genaera/Ludwig; Anti-interleukin-9 monoclonal antibody - Genaera/Ludwig; MEDI-528Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Genaera Corporation; Ludwig Institute for Cancer Research
- Developer MedImmune
- Class Antiasthmatics; Monoclonal antibodies
- Mechanism of Action Interleukin 9 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 01 Oct 2011 Discontinued - Phase-II for Asthma in Argentina (SC)
- 01 Oct 2011 Discontinued - Phase-II for Asthma in Brazil (SC)
- 01 Oct 2011 Discontinued - Phase-II for Asthma in Canada (SC)